EA
BDSI

Emerald Acquisition’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Emerald Acquisition’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.88M Sell
1,065,918
-83,175
-7% -$211K 0.01% 1554
2016
Q2 		$2.71M Buy
+1,149,093
New +$3.17M ﹤0.01% 1679

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Emerald Acquisition's BDSI Position: Q3 2016 in Review

Emerald Acquisition reduced its BioDelivery Sciences International, Inc. (BDSI) stake by 7.2% in Q3 2016, selling an estimated $211K and leaving 1,065,918 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #1554.

Emerald Acquisition first reported a position in BDSI in Q2 2016 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold BDSI as of Q3 2016.

  • Emerald Acquisition held 1,065,918 shares of BioDelivery Sciences International, Inc. worth $2.88M as of Q3 2016.
  • Emerald Acquisition sold 83,175 BioDelivery Sciences International, Inc. shares in Q3 2016, an estimated $211K.
  • BioDelivery Sciences International, Inc. made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1554 holding.
  • Emerald Acquisition first reported a position in BioDelivery Sciences International, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 85 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.